Maegim

Stock search

Search by company name, 6-digit code, or Korean initials (e.g. ㅅㅅㅈㅈ)

한국어

NGeneBio Co., Ltd.

엔젠바이오354200KOSDAQSector: Others
₩1,4991.64%Market cap ₩13.4BAs of Sep 7, 2026 close · updated once daily
Market cap
₩13.4B
#1700 in KOSDAQ
Loss
PER not computable
0.59x
Sector median 0.77x
0.0%
Sector median 0.6%
D
Grade D34.7 ptsBottom 22% of 2,522 graded stocksMethodology v2.0

As of Sep 7, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

How to read this grade
SABCDCurrentF

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,522 graded stocks and is currently in band D with a total score of 34.7 points.

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 136 stocks in Others

1-year closing price

Loading closing price history…
 
Low ₩1,283High ₩6,466
Latest close
Price change by period
1W
18.70%
1M
17.90%
3M
38.40%
1Y
66.60%

Adjusted for 2 price-basis change(s) such as stock splits or reverse splits during the period.

As of the Sep 7, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

1

Financial strength

9.1/100
How much debt does it carry relative to equity?
220.2%
Sector median 80.3%
Sector lowhighBottom 13% in sector
Can it cover what's due within a year?
50.8%
Sector median 144.8%
Sector lowhighBottom 8.5% in sector
How much of revenue becomes profit?
-39.0%
Sector median 4.8%
Sector lowhighBottom 5.6% in sector
How much did it earn on its own capital?
-24.1%
Sector median 5.2%
Sector lowhighBottom 9.3% in sector

Source filing: annual report (consolidated) — view original

2

Growth momentum

78.8/100
How much did revenue grow in a year?
273.2%
Sector median 3.2%
Sector lowhighTop 1.2% in sector
Has it grown steadily over three years?
24.5%
Sector median 0.9%
Sector lowhighTop 8% in sector
Did core profits grow in a year?
48.5%
Sector median 12.1%
Sector lowhighTop 27.7% in sector
Are core profits higher than three years ago?
3.8%
Sector median -0.4%
Sector lowhighTop 48.1% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (consolidated) — view original

3

Price attractiveness

34.1/100
Is the price expensive relative to earnings?
Loss-making (P/E not computable)
Sector median P/E of profitable peers 10.9x · 26% loss-making
Sector lowhighBottom 4.1% in sector
Is the price expensive relative to book value?
0.59x
Sector median 0.77x
Sector lowhighTop 35.9% in sector

Valuation uses the Sep 7, 2026 close and market cap

4

Shareholder Return

Single-indicator axis24.1/100
Does the company actually pay dividends?
0.0%
Sector median 0.6%
Sector lowhighBottom 24.1% in sector

Source filing: annual report (consolidated) — view original

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 7, 2026

Of 9 items: 3 met · 6 not met · 0 not computable

Not metMetNot computable

Positive net income
Whether net income (attributable to owners where available) is above zero.
Not met
-₩5.5B
Positive operating cash flow
Whether cash flow from operations is above zero.
Not met
-₩8.5B
Return on assets up
Whether net income over beginning total assets rose from the prior year.
Met
-29.9% → -16.8%
Operating cash flow exceeds net income
Whether operating cash flow is greater than net income.
Not met
-₩8.5B vs -₩5.5B
Liabilities-to-assets ratio down
Whether total liabilities as a share of total assets fell from the prior year.
Not met
46.3% → 68.8%
Current ratio up
Whether current assets over current liabilities rose from the prior year.
Not met
93.2% → 50.8%
Shares outstanding not increased
Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.
Not met
19,818,734 → 25,038,128
Operating margin up
Whether operating income over revenue rose from the prior year.
Met
-282.5% → -39.0%
Asset turnover up
Whether revenue over beginning total assets rose from the prior year.
Met
0.13x → 0.64x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (consolidated) — view original

Grade change history

Jul 23, 2026D

Methodology version change (v2.0 applied)

Jul 15, 2026DVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Disclosure & financial badges

Factual records determined from public filings and periodic reports by fixed rules — not buy/sell signals.

Negative-evidence group (dilution, loss, dispute)Mixed interpretationPositive-evidence group (shareholder return)Dots classify the disclosure type by the direction of research evidence — not an assessment or investment judgment about this company.

Disclosure event history

Large paid-in capital increase resolved

Disclosed a paid-in capital increase (제3자배정증자) issuing 4,685,778 new shares, equal to 23.6% of shares outstanding before the increase (filed 2025-06-27). View filing

Private CB/BW issuance resolutions (past 36 months)

3 private-placement convertible bond (CB) / bond-with-warrants (BW) issuance resolutions were disclosed in the past 36 months (latest filing 2025-10-15). View filing

CB with conversion-price adjustment clause (past 36 months)

2 convertible bond (CB) issuance resolutions including a downward conversion-price adjustment (refixing) clause were disclosed in the past 36 months (latest filing 2024-09-20). View filing

Largest-shareholder changes (past 36 months)

The largest shareholder changed 2 times in the past 36 months (latest change 2025-06-02, per annual report).

Financial fact combinations

Operating losses for 3 consecutive fiscal years

Recorded operating losses in three consecutive fiscal years, FY2023–FY2025 (per annual reports).

Determined as of 2026-09-07

Recent filings for this stock

Last 120 days · monitored filing types only
Paid-in capital increaseSep 7, 2026Source
Periodic report filedAug 14, 2026Source
Periodic report filedMay 15, 2026Source

View in the filings calendar →